{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T20:59:56Z","timestamp":1775509196264,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T00:00:00Z","timestamp":1580256000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T00:00:00Z","timestamp":1580256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2020,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>An existing clinical problem in Japan is the high prevalence of uncontrolled hypertension despite the availability of various effective therapies. Here, we analyzed survey data to gain insight into this paradox from physicians\u2019 perspectives, with results categorized according to specialty (i.e., with or without certification by the Japanese Society of Hypertension [JSH]), institution type, gender, and age. A web-based survey of typical educational activities for patients regarding hypertension management was conducted in Japan between October 19 and 31, 2017. Differences between physician groups were investigated per category. Survey results from 541 physicians were analyzed: 59 JSH certified (i.e., \u2018specialist\u2019) vs 482 non-JSH certified (i.e., \u2018nonspecialist\u2019) physicians; 192 general practitioners vs 349 hospital physicians; 500 males vs 41 females; and 178 younger (mean age: 40.7 years), 174 middle-aged (52.0 years) or 189 older (61.3 years) physicians. The most statistically significant differences between groups were observed in the category of physician specialty. Compared with nonspecialists, specialist physicians were more conscious of providing education on patient lifestyle modifications, more aware of patient- and physician-derived issues, and understood and followed the treatment guidelines. General practitioners cared more about the patient\u2019s burden than did hospital physicians. Younger physicians identified the need to incorporate the patient\u2019s perspective into their treatment. This analysis shows that the provision and perceptions of education differ between physician categories. Compared with specialist physicians, nonspecialists were less likely to provide adequate guidance on lifestyle modifications, possibly due to their uncertainty in understanding treatment guideline recommendations. Further education of nonspecialists on hypertension management may be warranted.<\/jats:p>","DOI":"10.1038\/s41440-019-0365-9","type":"journal-article","created":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T08:02:54Z","timestamp":1580284974000},"page":"431-441","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Perspectives of patients and physicians regarding hypertensive management from an online survey for excellence: a subanalysis of the PARADOX study by physician categories"],"prefix":"10.1038","volume":"43","author":[{"given":"Takuo","family":"Yoshida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiro","family":"Nishigaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shun","family":"Saita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Shimasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoyuki","family":"Hasebe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,29]]},"reference":[{"key":"365_CR1","doi-asserted-by":"publisher","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"PK Whelton","year":"2018","unstructured":"Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines. J Am Coll Cardiol. 2018;71:e127\u2013e248.","journal-title":"J Am Coll Cardiol"},{"key":"365_CR2","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC\/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021\u2013104.","journal-title":"Eur Heart J"},{"key":"365_CR3","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/hr.2013.80","volume":"37","author":"K Shimamoto","year":"2014","unstructured":"Shimamoto K, Ando K, Fujita T, Hasebe N, Higaki J, Horiuchi M, et al. The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2014). Hypertens Res. 2014;37:253\u2013390.","journal-title":"Hypertens Res."},{"key":"365_CR4","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1056\/NEJMsa0903829","volume":"361","author":"AV Chobanian","year":"2009","unstructured":"Chobanian AV. Shattuck Lecture. The hypertension paradox-more uncontrolled disease despite improved therapy. N. Engl J Med. 2009;361:878\u201387.","journal-title":"N. Engl J Med"},{"key":"365_CR5","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1253\/circj.CJ-13-0847","volume":"77","author":"K Miura","year":"2013","unstructured":"Miura K, Nagai M, Ohkubo T. Epidemiology of hypertension in Japan: where are we now? Circ J. 2013;77:2226\u201331.","journal-title":"Circ J."},{"key":"365_CR6","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1161\/HYPERTENSIONAHA.118.11203","volume":"71","author":"K Kario","year":"2018","unstructured":"Kario K, Wang JG. Could 130\/80 mm Hg be adopted as the diagnostic threshold and management goal of hypertension in consideration of the characteristics of Asian populations? Hypertension. 2018;71:979\u201384.","journal-title":"Hypertension."},{"key":"365_CR7","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1177\/2047487317709116","volume":"24","author":"ME van Kleef","year":"2017","unstructured":"van Kleef ME, Spiering W. Hypertension: overly important but under-controlled. Eur J Prev Cardiol. 2017;24:36\u201343.","journal-title":"Eur J Prev Cardiol"},{"key":"365_CR8","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/1471-2296-15-130","volume":"15","author":"JP Lebeau","year":"2014","unstructured":"Lebeau JP, Cadwallader JS, Aubin-Auger I, Mercier A, Pasquet T, Rusch E, et al. The concept and definition of therapeutic inertia in hypertension in primary care: a qualitative systematic review. BMC Fam Pr. 2014;15:130.","journal-title":"BMC Fam Pr"},{"key":"365_CR9","unstructured":"Japan Health Sciences Foundation, Ed. Report on basic technology study. Survey of medical needs of 60 diseases, and other unmet medical needs. Japan Health Sciences Foundation: Japan; 2014."},{"key":"365_CR10","doi-asserted-by":"publisher","unstructured":"Nishigaki N, Shimasaki Y, Yoshida T, Hasebe N. Physician and patient perspectives on hypertension management and factors associated with lifestyle modifications in Japan: results from an online survey. (2019). https:\/\/doi.org\/10.1038\/s41440-020-0398-0.","DOI":"10.1038\/s41440-020-0398-0"},{"key":"365_CR11","unstructured":"Nikkei Business Publications Inc. Online Marketing Report. Nikkei Business Publications Inc: Japan; 2018."},{"key":"365_CR12","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/jch.12105","volume":"15","author":"JR Turner","year":"2013","unstructured":"Turner JR. Patient and physician adherence in hypertension management. J Clin Hypertens (Greenwich). 2013;15:447\u201352.","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"365_CR13","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1377\/hlthaff.2009.0450","volume":"29","author":"W Levinson","year":"2010","unstructured":"Levinson W, Lesser CS, Epstein RM. Developing physician communication skills for patient-centered care. Health Aff (Millwood). 2010;29:1310\u20138.","journal-title":"Health Aff (Millwood)"},{"key":"365_CR14","first-page":"1982","volume":"69","author":"T Hano","year":"2011","unstructured":"Hano T. Improvement of adherence in the treatment of hypertension. Nihon Rinsho. 2011;69:1982\u20136.","journal-title":"Nihon Rinsho"},{"key":"365_CR15","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1265\/jjh.66.608","volume":"66","author":"H Tobari","year":"2011","unstructured":"Tobari H, Yamagishi K, Iso H. An occupational physician-pharmacist cooperative management for hypertension by the use of educational letters and posters. Nihon Eiseigaku Zasshi. 2011;66:608\u201315.","journal-title":"Nihon Eiseigaku Zasshi"},{"key":"365_CR16","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1093\/ajh\/hpv186","volume":"29","author":"S Perl","year":"2016","unstructured":"Perl S, Niederl E, Kos C, Mrak P, Ederer H, Rakovac I, et al. Randomized evaluation of the effectiveness of a structured educational program for patients with essential hypertension. Am J Hypertens. 2016;29:866\u201372.","journal-title":"Am J Hypertens"},{"key":"365_CR17","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/hr.2016.42","volume":"39","author":"M Mogi","year":"2016","unstructured":"Mogi M, Hasebe N, Horiuchi M, Shimamoto K, Umemura S. The results of a survey of physicians about the Japanese Society of Hypertension Guidelines for the Management of Hypertension 2014 and its clinical use. Hypertens Res. 2016;39:660\u20133.","journal-title":"Hypertens Res"},{"key":"365_CR18","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/hr.2015.21","volume":"38","author":"T Obara","year":"2015","unstructured":"Obara T, Ubeda SR, Ohkubo T, Matsuura H, Ishimitsu T, Takata M, et al. Awareness of the Japanese Society of Hypertension Guidelines for the Management of Hypertension and their use in clinical practices: 2009 survey results. Hypertens Res. 2015;38:400\u20134.","journal-title":"Hypertens Res."},{"key":"365_CR19","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/sj.jhh.1001385","volume":"16","author":"Y Asai","year":"2002","unstructured":"Asai Y, Heller R, Kajii E. Hypertension control and medication increase in primary care. J Hum Hypertens. 2002;16:313\u20138.","journal-title":"J Hum Hypertens"},{"key":"365_CR20","unstructured":"World Health Organization. A global brief on hypertension: silent killer, global public health crisis. 2013. http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/79059\/WHO_DCO_WHD_2013.2_eng.pdf;jsessionid=31F2038798564ECA99A821F3FD8FF578?sequence=1. Accessed Oct 2018."},{"key":"365_CR21","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/s41440-018-0182-6","volume":"42","author":"JI Recio-Rodriguez","year":"2019","unstructured":"Recio-Rodriguez JI, Rodriguez-Sanchez E, Martin-Cantera C, Martinez-Vizcaino V, Arietaleanizbeaskoa MS, Gonzalez-Viejo N, et al. Combined use of a healthy lifestyle smartphone application and usual primary care counseling to improve arterial stiffness, blood pressure and wave reflections: a Randomized Controlled Trial (EVIDENT II Study). Hypertens Res. 2019;42:852\u201362.","journal-title":"Hypertens Res."},{"key":"365_CR22","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/s41440-018-0101-x","volume":"41","author":"M Yamashita","year":"2018","unstructured":"Yamashita M, Tabara Y, Higo Y, Setoh K, Kawaguchi T, Takahashi Y, et al. Association between socioeconomic factors and urinary sodium-to-potassium ratio: the Nagahama Study. Hypertens Res. 2018;41:973\u201380.","journal-title":"Hypertens Res"},{"key":"365_CR23","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMp1716193","volume":"378","author":"G Bakris","year":"2018","unstructured":"Bakris G, Sorrentino M. Redefining hypertension\u2014assessing the new blood-pressure guidelines. N Engl J Med. 2018;378:497\u20139.","journal-title":"N Engl J Med"},{"key":"365_CR24","doi-asserted-by":"publisher","first-page":"e306","DOI":"10.3399\/bjgp17X690461","volume":"67","author":"N Mejzner","year":"2017","unstructured":"Mejzner N, Clark CE, Smith LF, Campbell JL. Trends in the diagnosis and management of hypertension: repeated primary care survey in South West England. Br J Gen Pr. 2017;67:e306\u2013e13.","journal-title":"Br J Gen Pr"},{"key":"365_CR25","first-page":"e193","volume":"63","author":"J Kaczorowski","year":"2017","unstructured":"Kaczorowski J, Myers MG, Gelfer M, Dawes M, Mang EJ, Berg A, et al. How do family physicians measure blood pressure in routine clinical practice? National survey of Canadian family physicians. Can Fam Phys. 2017;63:e193\u2013e9.","journal-title":"Can Fam Phys"},{"key":"365_CR26","doi-asserted-by":"crossref","unstructured":"Ohishi M, Yoshida T, Oh A, Hiroi S, Takeshima T, Otsuka Y, et al. Analysis of antihypertensive treatment using real-world Japanese data-the retrospective study of antihypertensives for lowering blood pressure (REAL) study. Hypertens Res. 2019;42:1057\u201367.","DOI":"10.1038\/s41440-019-0238-2"},{"key":"365_CR27","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1080\/10641963.2018.1465074","volume":"41","author":"T Ishida","year":"2019","unstructured":"Ishida T, Oh A, Hiroi S, Shimasaki Y, Tsuchihashi T. Current prescription status of antihypertensive drugs in Japanese patients with hypertension: Analysis by type of comorbidities. Clin Exp Hypertens. 2019;41:203\u201310.","journal-title":"Clin Exp Hypertens"},{"key":"365_CR28","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1001\/jama.288.6.756","volume":"288","author":"DL Roter","year":"2002","unstructured":"Roter DL, Hall JA, Aoki Y. Physician gender effects in medical communication: a meta-analytic review. JAMA 2002;288:756\u201364.","journal-title":"JAMA"},{"key":"365_CR29","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0738-3991(99)00090-7","volume":"39","author":"E Krupat","year":"2000","unstructured":"Krupat E, Rosenkranz SL, Yeager CM, Barnard K, Putnam SM, Inui TS. The practice orientations of physicians and patients: the effect of doctor-patient congruence on satisfaction. Patient Educ Couns. 2000;39:49\u201359.","journal-title":"Patient Educ Couns"},{"key":"365_CR30","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1146\/annurev.publhealth.25.101802.123134","volume":"25","author":"DL Roter","year":"2004","unstructured":"Roter DL, Hall JA. Physician gender and patient-centered communication: a critical review of empirical research. Annu Rev Public Health. 2004;25:497\u2013519.","journal-title":"Annu Rev Public Health"},{"key":"365_CR31","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1001\/archinte.167.1.10","volume":"167","author":"GW Smetana","year":"2007","unstructured":"Smetana GW, Landon BE, Bindman AB, Burstin H, Davis RB, Tjia J, et al. A comparison of outcomes resulting from generalist vs specialist care for a single discrete medical condition: a systematic review and methodologic critique. Arch Intern Med. 2007;167:10\u201320.","journal-title":"Arch Intern Med"},{"key":"365_CR32","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/j.1365-2796.2008.01967.x","volume":"264","author":"HK Berthold","year":"2008","unstructured":"Berthold HK, Gouni-Berthold I, Bestehorn KP, Bohm M, Krone W. Physician gender is associated with the quality of type 2 diabetes care. J Intern Med. 2008;264:340\u201350.","journal-title":"J Intern Med"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41440-019-0365-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41440-019-0365-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41440-019-0365-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:22:13Z","timestamp":1684617733000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-019-0365-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,29]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["365"],"URL":"https:\/\/doi.org\/10.1038\/s41440-019-0365-9","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,29]]},"assertion":[{"value":"11 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"TY, NN, SS, and YS are employees of Takeda Pharmaceutical Co., Ltd., Tokyo. NH has received the following: (1) lecture fees from Takeda Pharmaceutical Industries, Ltd.; Japan Boehringer Ingelheim Co., Ltd.; Daiichi Sankyo Co., Ltd.; Dainippon Sumitomo Pharmaceutical Co., Ltd.; Mochida Pharmaceutical Co., Ltd.; and Bristol-Myers Squibb Co., Ltd.; (2) scholarship donations from Astellas Pharma Inc.; Otsuka Pharmaceutical Co., Ltd.; Daiichi Sankyo Co., Ltd.; Takeda Pharmaceutical Industries, Ltd.; Teijin Pharma Co., Ltd.; Bayer Pharmaceutical Co., Ltd.; Dainippon Sumitomo Pharmaceutical Co., Ltd.; Medical Corporation Nichiren Kitakyushu Hospital; Nishisei Hospital Enzankai; Genseikai group; Kaiseikai medical group; and Asahikawa Rehabilitation Hospital Shinwakai medical group; and (3) donations for cardiovascular regeneration and advanced medical development course.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}